Patient FAQ in html format with a link to approved labeling (as pdf).

Full prescribing information from RxList.

Introduction into new potential hair loss drug.

An FDA approved 5-alpha-reductase inhibitor for treatment of benign prostatic hyperplasia and alopecia.

Provides information on a new treatment for male pattern hair loss.

Gives a critical appraisal of this drug that Glaxo now calls Avodart. The drug is specifically for benign prostatic hyperplasia (BPH) but may also combat male pattern baldness.

Treatment of hair loss and benign prostate cancer.

Information on this DHT inhibitor also known as Avodart, Avolve, or Duagenand. Site includes a sales promotion for this hair loss medicine.